Evidence map›Paper›PMID 22169943›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Michael H Baumann, Mario A Ayestas, John S Partilla, Jacqueline R Sink, Alexander T Shulgin, Paul F Daley, Simon D Brandt, Richard B Rothman, Arnold E Ruoho, Nicholas V Cozzi

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 237 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
237citing papers in PubMed, 1 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

237 citing papers in PubMed, 1 synthesis or guideline pooled it, 434 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Human Pharmacology of Mephedrone in Comparison with MDMA.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  5. αMolecular psychiatry · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Methylone promotes neurite outgrowth and has long-lasting effects on fear extinction learning.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Effects of congeners of amphetamine on the human heart.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  18. The effect of mephedrone on human neuroblastoma and astrocytoma cells.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  19. Review
  20. Article

177 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Michael H BaumannTranslational Pharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. mbaumann@mail.nih.gov
Mario A Ayestas
John S Partilla
Jacqueline R Sink
Alexander T Shulgin
Paul F Daley
Simon D Brandt
Richard B Rothman
Arnold E Ruoho
Nicholas V Cozzi
National Institute on Drug Abuse · USNational Institutes of Health · USUniversity of Wisconsin–Madison · USLiverpool John Moores University · GB

Funding

Characterization of the Sigma-2 receptorR21DA027191 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI RUOHO, ARNOLD EINO · 2009 to 2010
$408k
Amphetamine-related photoaffinity probesR21DA017675 · NIDA · UNIVERSITY OF WISCONSIN MADISON · PI COZZI, NICHOLAS V · 2004 to 2005
$274k
Intramural NIH HHSNIDA NIH HHS DA017675NIDA NIH HHS DA027191NIDA NIH HHS R21 DA017675NIDA NIH HHS R21 DA027191
6 · The paper itself

Abstract

The nonmedical use of 'designer' cathinone analogs, such as 4-methylmethcathinone (mephedrone) and 3,4-methylenedioxymethcathinone (methylone), is increasing worldwide, yet little information is available regarding the mechanism of action for these drugs. Here, we employed in vitro and in vivo methods to compare neurobiological effects of mephedrone and methylone with those produced by the structurally related compounds, 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine. In vitro release assays using rat brain synaptosomes revealed that mephedrone and methylone are nonselective substrates for plasma membrane monoamine transporters, similar to MDMA in potency and selectivity. In vivo microdialysis in rat nucleus accumbens showed that i.v. administration of 0.3 and 1.0 mg/kg of mephedrone or methylone produces dose-related increases in extracellular dopamine and serotonin (5-HT), with the magnitude of effect on 5-HT being greater. Both methcathinone analogs were weak motor stimulants when compared with methamphetamine. Repeated administrations of mephedrone or methylone (3.0 and 10.0 mg/kg, s.c., 3 doses) caused hyperthermia but no long-term change in cortical or striatal amines, whereas similar treatment with MDMA (2.5 and 7.5 mg/kg, s.c., 3 doses) evoked robust hyperthermia and persistent depletion of cortical and striatal 5-HT. Our data demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to MDMA. Dopaminergic effects of mephedrone and methylone may contribute to their addictive potential, but this hypothesis awaits confirmation. Given the widespread use of mephedrone and methylone, determining the consequences of repeated drug exposure warrants further study.

Indexed as

Membrane Transport Proteins1-Methyl-4-phenylpyridiniumAnalysis of VarianceAnimalsChromatography, High Pressure LiquidDopamineDopamine Plasma Membrane Transport ProteinsDose-Response Relationship, DrugElectrochemistryHallucinogensIn Vitro TechniquesLocomotionMaleMethamphetamineMicrodialysisN-Methyl-3,4-methylenedioxyamphetamine1-Methyl-4-phenylpyridiniumDopamineDopamine Plasma Membrane Transport ProteinsHallucinogensMembrane Transport ProteinsmephedroneMethamphetaminemethyloneN-Methyl-3,4-methylenedioxyamphetamineNorepinephrine Plasma Membrane Transport ProteinsSerotoninTritium

Identifiers

PMID22169943
PMCPMC3306880
OpenAlexW2140901931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.